These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 26303175

  • 1. Rational Development of Nucleoside Diphosphate Prodrugs: DiPPro-Compounds.
    Meier C, Jessen HJ, Schulz T, Weinschenk L, Pertenbreiter F, Balzarini J.
    Curr Med Chem; 2015; 22(34):3933-50. PubMed ID: 26303175
    [Abstract] [Full Text] [Related]

  • 2. The DiPPro approach: synthesis, hydrolysis, and antiviral activity of lipophilic d4T diphosphate prodrugs.
    Schulz T, Balzarini J, Meier C.
    ChemMedChem; 2014 Apr; 9(4):762-75. PubMed ID: 24616176
    [Abstract] [Full Text] [Related]

  • 3. Nucleoside diphosphate prodrugs.
    Meier C, Jessen HJ, Balzarini J.
    Nucleic Acids Symp Ser (Oxf); 2008 Apr; (52):83-4. PubMed ID: 18776264
    [Abstract] [Full Text] [Related]

  • 4. Bis(benzoyloxybenzyl)-DiPPro nucleoside diphosphates of anti-HIV active nucleoside analogues.
    Weinschenk L, Gollnest T, Schols D, Balzarini J, Meier C.
    ChemMedChem; 2015 May; 10(5):891-900. PubMed ID: 25847660
    [Abstract] [Full Text] [Related]

  • 5. Nucleoside mono- and diphosphate prodrugs of 2',3'-dideoxyuridine and 2',3'-dideoxy-2',3'-didehydrouridine.
    Pertenbreiter F, Balzarini J, Meier C.
    ChemMedChem; 2015 Jan; 10(1):94-106. PubMed ID: 25209965
    [Abstract] [Full Text] [Related]

  • 6. Nucleoside Diphosphate Prodrugs: Nonsymmetric DiPPro-Nucleotides.
    Weinschenk L, Schols D, Balzarini J, Meier C.
    J Med Chem; 2015 Aug 13; 58(15):6114-30. PubMed ID: 26125628
    [Abstract] [Full Text] [Related]

  • 7. Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues.
    Jia X, Schols D, Meier C.
    J Med Chem; 2020 Jul 09; 63(13):6991-7007. PubMed ID: 32515595
    [Abstract] [Full Text] [Related]

  • 8. Anti-HIV-Active Nucleoside Triphosphate Prodrugs.
    Jia X, Schols D, Meier C.
    J Med Chem; 2020 Jun 11; 63(11):6003-6027. PubMed ID: 32421343
    [Abstract] [Full Text] [Related]

  • 9. γ-Non-Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV.
    Zhao C, Jia X, Schols D, Balzarini J, Meier C.
    ChemMedChem; 2021 Feb 04; 16(3):499-512. PubMed ID: 33089929
    [Abstract] [Full Text] [Related]

  • 10. Membrane Permeable, Bioreversibly Modified Prodrugs of Nucleoside Diphosphate-γ-Phosphonates.
    Jia X, Weber S, Schols D, Meier C.
    J Med Chem; 2020 Oct 22; 63(20):11990-12007. PubMed ID: 32991174
    [Abstract] [Full Text] [Related]

  • 11. Bioreversible protection of nucleoside diphosphates.
    Jessen HJ, Schulz T, Balzarini J, Meier C.
    Angew Chem Int Ed Engl; 2008 Oct 22; 47(45):8719-22. PubMed ID: 18833560
    [No Abstract] [Full Text] [Related]

  • 12. Lipophilic Nucleoside Triphosphate Prodrugs of Anti-HIV Active Nucleoside Analogs as Potential Antiviral Compounds.
    Jia X, Schols D, Meier C.
    Adv Sci (Weinh); 2023 Dec 22; 10(36):e2306021. PubMed ID: 37884485
    [Abstract] [Full Text] [Related]

  • 13. Nucleoside diphosphate and triphosphate prodrugs - An unsolvable task?
    Meier C.
    Antivir Chem Chemother; 2017 Dec 22; 25(3):69-82. PubMed ID: 29096525
    [Abstract] [Full Text] [Related]

  • 14. Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues.
    Gollnest T, Dinis de Oliveira T, Rath A, Hauber I, Schols D, Balzarini J, Meier C.
    Angew Chem Int Ed Engl; 2016 Apr 18; 55(17):5255-8. PubMed ID: 27008042
    [Abstract] [Full Text] [Related]

  • 15. Prodrugs of γ-Alkyl-Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase.
    Zhao C, Weber S, Schols D, Balzarini J, Meier C.
    Angew Chem Int Ed Engl; 2020 Dec 01; 59(49):22063-22071. PubMed ID: 32379948
    [Abstract] [Full Text] [Related]

  • 16. γ-Ketobenzyl-Modified Nucleoside Triphosphate Prodrugs as Potential Antivirals.
    Nack T, Dinis de Oliveira T, Weber S, Schols D, Balzarini J, Meier C.
    J Med Chem; 2020 Nov 25; 63(22):13745-13761. PubMed ID: 33186038
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
    Saboulard D, Naesens L, Cahard D, Salgado A, Pathirana R, Velazquez S, McGuigan C, De Clercq E, Balzarini J.
    Mol Pharmacol; 1999 Oct 25; 56(4):693-704. PubMed ID: 10496951
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs.
    Mackman RL, Zhang L, Prasad V, Boojamra CG, Douglas J, Grant D, Hui H, Kim CU, Laflamme G, Parrish J, Stoycheva AD, Swaminathan S, Wang K, Cihlar T.
    Bioorg Med Chem; 2007 Aug 15; 15(16):5519-28. PubMed ID: 17562366
    [Abstract] [Full Text] [Related]

  • 19. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
    Parang K, Wiebe LI, Knaus EE.
    Curr Med Chem; 2000 Oct 15; 7(10):995-1039. PubMed ID: 10911016
    [Abstract] [Full Text] [Related]

  • 20. Bis-ketol nucleoside triesters as prodrugs of the antiviral nucleoside triphosphate analogues of 3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine.
    Calvo KC, Wang X, Koser GF.
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct 15; 23(3):637-46. PubMed ID: 15113029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.